High daily intensive care unit (ICU) costs are associated with the use of mechanical ventilation (MV) to treat acute respiratory failure (ARF), and assessment of quality of life (QOL) after critical illness and cost-effectiveness analyses are warranted. This article finds that despite lower health-related QOL compared to reference values, our result suggests that cost per hospital survivor and lifetime cost-utility remain reasonable regardless of age, disease severity, and type or duration of ventilation support in patients with ARF.
Linko, R., Suojaranta-Ylinen, R., Karlsson, S., Ruokonen, E., Varpula, T., & Pettila, V. Y. O. (2010). One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure. Critical Care, 14(2 (R60)), 1 - 9. https://doi.org/10.1186/cc8957